8-Week Atopic Dermatitis (AD) Treatment Study
Clinical trial NCT03386032 · COMPLETED
Trial details
- NCT number
- NCT03386032
- Sponsor
- Procter and Gamble
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2018-08-18
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.